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Mice deﬁcient in the CD4 molecule (CD4/) are widely used to evaluate the requirement for CD4þ T cell help in
viral, tumoral, and transplantation immunity. Previous studies, showing that CD4/ mice develop impaired con-
tact hypersensitivity (CHS) responses, have suggested that CD4þ T cells are required for the optimal induction of
this skin inﬂammatory reaction. other studies have, however, demonstrated that CHS was mediated by CD8þ T
cells, without the need for CD4þ T cell help. Here, we show that CD4/ mice develop a normal delayed-type
hypersensitivity response to protein antigen, which is mediated by major histocompatibility molecules class II-
restricted CD4CD8 T cells, but a decreased CHS response to 2,4-dinitro-ﬂuorobenezene. Analysis of the hapten-
specific T cell pool demonstrates that priming of CD8þ T cells occurred normally in CD4/ mice, as assessed by
specific proliferative responses and interferon-c (IFN-c) production of puriﬁed CD8þ T cells. Furthermore, CD8þ T
cells were able to adoptively transfer a normal CHS reaction. In contrast, total lymph node cells from CD4/ mice
showed decreased IFN-c production and diminished specific cytotoxic T lymphocytes (CTL) activity, which could
be reversed by in vitro restimulation with hapten-pulsed class II-deﬁcient antigen-presenting cells. These data
conﬁrm that class I-restricted CD8þ T cells can fully develop in effectors of CHS in the absence of CD4þ T cell
help and suggest that the impaired CHS in CD4/ mice is because of the presence of a class II-restricted T cell
subset, which controls CHS by inhibiting hapten-specific CTL responses.
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Contact hypersensitivity (CHS) is a T cell-mediated skin in-
flammatory reaction that occurs after cutaneous exposure
to haptens. Skin dendritic cells (DC) uptake haptens, ex-
press haptenated peptides in the groove of major histo-
compatibility molecules class I and II molecules (MHC) and
migrate to the draining lymph nodes (LN) where they acti-
vate CD4þ and CD8þ T cell precursors (Xu et al, 1996;
Krasteva et al, 1999). Several studies by independent in-
vestigators and using different haptens have shown that
CHS was mediated by CD8þ T cells (Gocinski and Tigelaar,
1990; Bour et al, 1995; Kolesaric et al, 1997; Bouloc et al,
1998; Martin et al, 2000; Saint-Mezard et al, 2003) that ex-
pand in lymphoid organs and are recruited in the skin at the
site of hapten challenge where they induce keratinocyte
apoptosis through cytotoxic T lymphocytes (CTL) activity
(Xu et al, 1997; Kehren et al, 1999; Akiba et al, 2002).
The contribution of CD4þ T cells in CHS remains, how-
ever, disputed. Indeed, mice deficient in MHC class II mol-
ecules (class II/), which are devoid of circulating CD4þ
T cells, as well as mice depleted in CD4þ T cells by in vivo
treatment with anti-CD4 monoclonal antibody (mAb), de-
velop an enhanced and prolonged CHS reaction compared
with normal mice (Gocinski and Tigelaar, 1990; Bour et al,
1995; Kolesaric et al, 1997; Bouloc et al, 1998). This implies
that: (i) CD8þ T cells can fully develop into CTL effectors
in the absence of CD4þ T cells; (ii) CD4þ T cells do not
contribute to the effector phase of CHS; and (iii) CD4þ T
cells comprise cells that downregulate CHS (Bour et al,
1995; Xu et al, 1996; Dubois et al, 2003b).
Kondo et al, however, observed that CHS to 2,4-dinitro-
fluorobenezene (DNFB) and oxazolone was impaired in
CD4-deficient mice (CD4/) suggesting that CD4þ T
cells are either important for the full development of CHS
(CD4þ T cell help) or behave as effector cells of CHS (Ko-
ndo et al, 1996; Wang et al, 2000). The reason for the dif-
ferences between the results obtained in CD4/ mice and
those reported by other investigators using class II/ mice
or CD4þ T cell-depleted wild-type (wt) mice most like-
ly reflects important functional differences between the
CD4/ mouse and other strains. Indeed, the fact that
the CD4 molecule has been knockedout does not mean that
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the mice are deficient in cells that normally express the
CD4þ T cell function. In other words, the CD4/ mice do
not have the CD4 molecule but may still have most, if not all,
of the helper cell activity usually assigned to the CD4þ T
cell subset. In this respect, CD4/ mice can develop nor-
mal class II-restricted T cell reactions in vivo and antigen-
specific proliferative responses in vitro (Locksley et al, 1993;
Rahemtulla et al, 1994). Based on these observations, we
consider that the diminished CHS reaction in CD4/ mice
cannot be explained by a lack of class II-restricted T cells.
To understand the discrepancies in the results obtained
with CD4/ versus class II/ mice, we tested the CHS
reaction to DNFB and the development of anti-hapten
CD8þ Tcell functions in CD4/, CD4þ /, and class II/
mice. First, we show that CD4/ mice develop normal
class II-restricted delayed-type hypersensitivity (DTH) reac-
tions to the nominal protein antigen keyhole limpet
hemocyanin (KLH), confirming that CD8CD4 T cells
comprise lymphocyte subsets that are functionally equiva-
lent to the CD4þ T cell subset of mice expressing the CD4
molecule (Locksley et al, 1993; Rahemtulla et al, 1994). In
contrast, CHS reaction was impaired in these mice, as pre-
viously described (Kondo et al, 1996). Analysis of the CD8þ
T cell pool showed that the absence of the CD4 molecule
potently impaired the hapten-specific CD8þ T cell func-
tions, including CTL activity, without affecting their priming
and expansion. Such deficient CD8þ T cell functions ap-
peared to be mediated by class II-restricted T cells since
restimulation of CD8þ T cells with class II-deficient anti-
gen-presenting cells (APC) restored a normal level of CD8þ
T cell activity. In conclusion, these results show that the
impaired CHS reaction in CD4/ mice is not because of
an intrinsic defect in hapten-specific CD8þ T cell functions
but rather to regulatory/suppressive mechanisms.
Results
CD4/ mice exhibit normal MHC class II-restricted, but
impaired MHC class I-restricted skin DTH reactions In
order to better characterize the outcome of T cell-mediated
inflammatory responses in CD4/ mice, two types of skin
DTH reactions were assayed: DTH to the nominal protein
antigen KLH in a footpad swelling assay and CHS to the
hapten DNFB in a mouse ear swelling test. Responses of
CD4/ and class II/ mice were compared. CD4þ /
mice were used as controls. Class II-deficient mice that lack
class II-restricted CD4þ T cells did not develop DTH to
KLH, confirming that DTH to proteins is mediated by class
II-restricted, CD4þ T cells (Fig 1a). In contrast, class II/
mice developed an enhanced CHS to DNFB (Fig 1b), con-
firming our previous results showing that the hapten-
specific inflammatory response is mediated by MHC class
I-restricted, CD8þ T cells, and that CD4þ T cells exert
downregulatory functions (Bour et al, 1995).
Conversely to class II/ mice, CD4/ mice mounted
a normal DTH reaction to KLH (Fig 1a), which was unaf-
fected by depletion of CD8þ T cells, indicating that effector
cells of the DTH response are present within the
CD4CD8 T cell subset. Thus, as previously reported,
the absence of the CD4 molecule cannot be considered as
lack of a functional class II-restricted T cell subset (Ra-
hemtulla et al, 1994). More importantly, the CD8þ T cell-
mediated CHS to DNFB was greatly reduced in CD4/
mice and associated with moderate ear swelling (Fig 1b)
and skin infiltration with inflammatory cells (data not shown).
These results were surprising since the percentage of
CD8þ T cells is higher in CD4/ mice compared with
CD4þ / mice (Fig 2) and since CD8þ Tcell functions have
been reported to be conserved in these animals (Rahemtulla
et al, 1991).
Thus, paradoxically, CD4/ mice develop impaired
CD8þ , but normal ‘‘CD4þ Tcell’’-mediated DTH reactions.
Priming of hapten-specific CD8þ T cells occurs nor-
mally in CD4/ mice To determine whether the lack of
Figure1
The absence of CD4 molecules or major histocompatibility mole-
cules class II-restricted CD4þ T cells have opposite effects on
contact hypersensitivity (CHS) and delayed-type hypersensitivity
outcome. (a) Groups of five CD4/, CD4þ /, and class II/ mice
were sensitized with KLH (white bars) or left untreated (black bars), and
challenged 7 d later on the left footpad. Results are expressed as the
mean footpad swelling (mm) at 24 h after challenge. Hatched bars rep-
resent the mean footpad swelling of CD8þ T cells depleted sensitized
animals. (b) CHS to 2,4-dinitro-fluorobenezene (DNFB) was analyzed in
groups of five wild-type C57BL/6 (m), CD4þ / (’), CD4/ (  ) or
class II/ (~). Mice were either sensitized with DNFB or desensitized
(not shown) and challenged 5 d later on the left ear. Results are ex-
pressed as the mean ear swelling (mm) at different time points after
challenge. Results are representative of three independent experiments.
IMPAIRED CTL FUNCTIONS IN CD4/ MICE 563124 : 3 MARCH 2005
CHS reaction in CD4/ mice is secondary to an impair-
ment in the afferent phase of CHS, we first checked the
functional properties of DC. Migration of skin DC to draining
LN was tested using fluorescein isothiocyanate (FITC)
painting experiments (Macatonia et al, 1987) where FITC
was applied onto the ventral skin of CD4þ / and CD4/
mice, and the number of FITCþ /CD11cþ cells (defining
the migrating skin DC) in draining LN was analyzed 24 h
later. The percentage of FITCþDC cells recovered from
skin draining LN was comparable in the two types of mice
(Fig S1a). Ability of DC to prime for specific T cells was done
by immunization of naive C57BL/6 mice by s.c. injection of
dinitrobenzenesulfonic acid (DNBS)-pulsed bone-marrow-
derived DC, followed 5 d later by ear challenge with DNFB.
DC from CD4þ / and CD4/ mice were equally efficient
to transfer a CHS reaction in recipient mice (Fig S1b). To-
gether, these data suggest that the impairment of CHS re-
sponses in CD4/ mice could not be attributed to an
alteration of DC functions during the afferent phase of CHS.
In order to test for CD8þ T cell priming in lymphoid or-
gans, CD4/ and CD4þ / mice were sensitized with
DNFB and lymphoid cells were recovered 5 d later and
tested for hapten-specific proliferative responses (Fig 3).
Total LN cells from CD4/ mice responded vigorously to
hapten-treated syngeneic cells in secondary proliferative
responses, with c.p.m. counts increased compared with
those observed with total LN cells recovered from CD4þ /.
This difference strongly correlates to the increased number
of CD8þ T cells found in the LN of CD4/ mice compared
with that of CD4þ / mice (Fig 2). Along this line, purified
CD8þ T cells showed a strong but similar hapten-specific
proliferation in both types of mice, and CD8-depleted T cells
from CD4/ mice, i.e. CD4CD8 T cells, exhibited a low
hapten-specific response indistinguishable from those of
control cells (Fig 3a).
Next, the in vivo functional properties of purified LN
CD8þ T cells from CD4þ / and CD4/ animals were
analyzed by transferring CHS in naive recipients by i.v. in-
jection of 107 purified CD8þ T cells recovered from the LN
of DNFB-sensitized CD4þ / or CD4/ mice. Challenge
with 0.15% DNFB was performed immediately after trans-
fer. As shown in Fig 3b, CD8þ T cells from CD4/ mice
were as efficient in transferring CHS as CD8þ T cells from
CD4þ / mice. Unexpectedly, these data show that CD8þ
effector T cells of CHS develop normally in CD4/ mice.
CD8þ T cells migrate to the challenged skin of CD4/
mice, but fail to produce interferon (IFN)-c in vivo Since
the CHS reaction to DNFB is associated with the infiltration
of IFN-g-producing CD8þ T cells in situ a few hours after
challenge, we examined the presence of CD8þ T cells and
Figure 2
Fluorescence-activated cell sorting (FACS) analysis of lymph node
(LN) cells from CD4/ and CD4þ / mice. Cells were purified from
draining LN of 10 CD4þ / or CD4/ mice, 5 d after the 2,4-dinitro-
fluorobenezene sensitization. The percentage of CD8þ , CD4þ , and
CD4CD8 T cells was analyzed by FACS. Number of cells represents
the average number of CD8þ T cells in one draining lymph node.
Figure3
Hapten-specific T cells responses in CD4/ and CD4þ / mice.
(a) Secondary proliferative responses. Total lymph node (LN) cells (LN),
purified CD8þ T cells (8þ ) and CD8þ T cell-depleted LN cells (8)
were recovered from 2,4-dinitro-fluorobenezene (DNFB)-sensitized
CD4/ (black bars) and CD4þ / mice (white bars) 5 d after sen-
sitization and tested for proliferative responses to hapten-modified (þ )
or unmodified () syngenic spleen cells in a 6 h 3(H) thymidine assay. (b)
Contact hypersensitivity response after the adoptive transfer of CD8þ
T cells from DNFB-sensitized CD4/ and CD4þ / mice (five mice
per group). CD8þ T cells were recovered from draining LN at days 5
and 10. 106 cells were transferred in the retro-orbital sinus of naive
class II/ recipient mice. Challenge with 0.15% DNFB was performed
immediately after transfer. Results are expressed as the mean ear
swelling (mm) 48 h after the challenge. Results are representative of
three independent experiments.
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the expression of IFN-g in the skin of CD4/ and CD4þ /
mice after sensitization and challenge. PCR analysis (Fig 4a)
demonstrated that CD8 and IFN-g mRNA were not found (or
found at very low levels) in the ears of naive mice or in
hapten-painted ears of desensitized mice. CD8 mRNA
could be detected as early as 9 h after challenge in both
types of mice, but the in situ IFN-g mRNA production was
dramatically decreased in the CD4/ mice. In CD4þ /
mice, CD8 and IFN-g mRNA progressively increased there-
after, reaching a peak around 24–48 h. Alternatively, in
CD4/ mice, CD8 and IFN-g mRNA levels remained low
from 9 to 48 h post-challenge (Fig 4b). These data indicate
that, early after challenge (i.e. 9 h), CD8þ T cells from
CD4/ mice are able to migrate to the skin but, conversely
to CD4þ / mice, do not produce IFN-g in situ, a mech-
anism associated with the initiation and the development of
CHS response (Kehren et al, 1999; Akiba et al, 2002).
Impaired effector functions of CD8þ T cells in CD4/
mice To determine whether the deficient CHS response in
CD4/ mice is indeed secondary to impaired CD8þ T cell
effector functions, we tested whether IFN-g production and
CTL activity was affected by CD4 molecule deficiency. First,
we analyzed the production of IFN-g mRNA and protein by
anti-CD3 stimulated total LN cells, purified LN CD8þ T cells
and LN cells depleted in CD8 Tcells from sensitized CD4/
and CD4þ / mice (Fig 5). This condition of T cell stimu-
lation is unable to induce IFN-g production by LN cells from
desensitized mice (data not shown). The production of
IFN-g by total LN cells was lower in CD4/ compared with
CD4þ / mice as assessed by RNAse protection assay
(Fig 5a, b) and ELISA (Fig 5c). Purified CD8þ T cells from
both types of mice, however, produced similar high
amounts of IFN-g mRNA and protein whereas CD8þ T
cell-depleted LN cells produced only very limited amounts
of IFN-g. This result demonstrates that CD4/ mice have
no intrinsic deficiency of IFN-g-producing CD8þ T cells but
present a particular deficit when mixed with total LN cells.
Next, lymphoid cells from CD4/, CD4þ /, and class
II/ mice were recovered on day 5 after sensitization and
tested for hapten-specific CTL activity. Splenocytes from
CD4/ mice showed decreased hapten-specific lysis as
compared with control CD4þ / splenocytes, whereas no sig-
nificant difference could be observed between class II/
and CD4þ / effectors (Fig 6a). Similar results were ob-
tained in experiments conducted with purified T cells from
draining LN, confirming that specific CTL activity was re-
duced by 50% in CD4/ mice (Fig 6b). Moreover, no sig-
nificant differences were observed when restimulatory cells
were from CD4/ or CD4þ / mice (Fig 6c and d), ruling
out a putative functional defect in CD4/ APC during the
restimulatory process. It is interesting to note that CD4/
cytotoxic activity was not totally abolished but decreased in
Figure 4
Detection of CD8 and interferon-c (IFN-c) mRNA during the elici-
tation phase of contact hypersensitivity. (a) CD8 and IFN-g mRNA
expression in situ was analyzed using semi-quantitative RT-PCR:
mRNA was obtained from the ears of mice at 9, 18, 24, and 48 h
after the challenge. Controls include ears of untreated mice (n.t). (b)
Histogram representation of the CD8 and IFN-g mRNA relative quan-
tities as compared with hypoxanthine phosphoribosyltransferase
(HPRT) mRNA as standard. Each band of (a) was analyzed by densi-
tometry and the results expressed as ratios of optical densities to HPRT
band.
Figure5
Interferon-c (IFN-c) production by CD8þ Tcells. (a) The level of IFN-
gmRNA in total lymph node (LN) cells (tLN cells), in CD8 Tcell-depleted
LN cells (8 LN cells) and in purified CD8 T cells (8þ cells) was meas-
ured by RNase protection assay. Cells were restimulated with coated
anti-CD3 monoclonal antibody (mAb) for 4 h before mRNA extraction.
(b) Results are expressed as the relative ratio between IFN-g and
GAPDH signals. (c) IFN-g production by different LN cell subsets re-
stimulated with coated anti-CD3 mAb for 24 h and assessed by ELISA.
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the same proportion (roughly 50%) as the in vivo CHS
reaction.
Then, we assessed the CTL activity of CD4/ T cells
after in vitro restimulation with hapten-derivatized Iþ /II
splenocytes, recovered from class II/ mice. This protocol
was previously shown to activate CD8þ CTL, without stim-
ulation of MHC class II-restricted downregulatory T cells, in
normal mice (Krasteva et al, 1998). CD4þ / effector cells,
including splenocytes (Fig 6e) or purified T cells from drain-
ing LN (Fig 6f ) exhibited similar CTL activities when restim-
ulated with either Iþ /II or Iþ /IIþ APC. In contrast,
CD4/ effectors exhibited a dramatic increase in their
hapten-specific CTL activity when restimulated with APC
lacking MHC class II molecule (i.e. with haptenated Iþ /II
splenocytes), with values of specific lysis similar to that of
effectors from CD4þ / and class II/ mice (Fig 6e, f ).
These results show that the decreased CTL activity ob-
served in CD4/ mice is not an intrinsic characteristic of
hapten-specific CD8þ T cells but seems to be dependent
on concomitant activation of an MHC class II-restricted
T cell subset present in CD4/ mice. This population
might behave as downregulatory cells that could inhibit the
function of hapten-specific CD8þ CTL.
Discussion
This work highlights the peculiar Tcell responses of CD4/
mice, characterized by impaired CHS responses to haptens
but normal DTH responses to proteins. Our study shows
that DTH to KLH that is mediated by class II-restricted
T cells (Bour et al, 1995; Tsicopoulos et al, 1999) was absent
in class II/ mice but maintained in CD4/ mice at a
level similar to that observed in C57BL/6 mice, indicating
that effector cells are CD4þ T cells in C57BL/6 mice and
CD4CD8 T cells in CD4/ mice.
Alternatively, CHS reactions to DNFB, which are induced
by CD8þ CTL (Cavani et al, 2001) were enhanced in class
II/ mice but impaired in CD4/ mice. Although the lat-
ter observation was previously interpreted as CD4þ T cells
being effectors of CHS (Fujisawa et al, 1996; Kondo et al,
1996; Wang et al, 2000), these data demonstrate that the
reduced CHS reaction in CD4/ mice is because of the
impaired effector functions of hapten-specific CD8þ T
cells. Priming of specific CD8þ T cells occurred normally in
the LN of sensitized CD4/ mice compared with CD4þ /
mice, as shown by optimal proliferative responses of puri-
fied CD8þ T cells. Furthermore, CD8þ T cells were able to
transfer an optimal CHS reaction to naive recipients. In the
presence of class II-restricted T cells, however, hapten-
specific CD8þ T cells presented a profound impairment in
IFN-g production and CTL activity, in vivo and in vitro. Col-
lectively, these data suggest that hapten-specific CD8þ T
cells can fully develop in CD4/ mice but that their effec-
tor functions are blocked by yet uncharacterized downreg-
ulatory/suppressive mechanisms.
Since CD4 is present on a subset of murine APC (Vremec
et al, 2000), the diminished CD8þ T cell priming and CHS
reaction in CD4/ mice could have been explained by a
deficient hapten-presenting cell function during sensitizat-
ion. Several observations, however, rule out this possibility:
(i) skin DC migration and immunization with hapten-pulsed
BMDC were similar in CD4/ and CD4þ / mice (Fig S1);
(ii) APC from either CD4/ or CD4þ / mice were similarly
efficient in stimulating hapten-specific secondary T cell
proliferation (data not shown) and cytotoxicity in vitro
(Fig 6a–d); and (iii) more importantly, CD8þ T cells purified
from lymphoid organs of sensitized CD4/ and CD4þ /
mice were as efficient in transferring CHS to naive recipients
(Fig 3b).
Figure 6
Anti-hapten cytotoxic T lymphocytes activity. Specific cytotoxic ac-
tivity was determined by lysis of hapten-pulsed EL-4 targets in a 4 h
51Cr release assay. Speen cells (a, c, e), or purified T cells (b, d, f), from
2,4-dinitro-fluorobenezene-sensitized CD4/ (  ), CD4þ / (’), or
class II/ (m) mice, were restimulated in vitro for 5 d with haptenated
CD4þ / (a, b), CD4/ (c, d), or class II/ (e, f) spleen antigen-
presenting cells. Results are representative of three independent
experiments.
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Previous studies have demonstrated that the magnitude
and duration of CHS depend both on the number and func-
tion of class I-restricted CTL effectors and the presence of
class II-restricted regulatory T cells (Treg) (for a review, see
Gorbachev and Fairchild, 2001). Our data provide evidence
that the impaired CD8þ T cell functions and CHS reactions
of CD4/ mice are not intrinsic to the CD8 population but
rather the consequence of class II-dependent suppressive/
regulatory mechanisms. Indeed, impaired hapten-specific
CD8þT cell functions (including IFN-g production and CTL
activity) were only observed in experimental settings using
unfractionated LN or spleen cells and not when purified
CD8þ T cells were tested. Moreover, in vitro restimulation
of CD8þ T cells from CD4/ mice by haptenated class II-
deficient DC restored a normal CTL activity, suggesting the
existence of class II-restricted regulatory cells in CD4/
mice. Two class II-restricted T cell subsets may be involved
in the reduced CHS reaction observed in CD4/ mice: (1)
CD4CD8 T cells, the so-called CD4 ‘‘wannabe’’ T cells
(Rahemtulla et al, 1991). It is assumed that these double-
negative CD4 lineage T cells express high-affinity T cell re-
ceptors (TCR) and can be positively selected in the thymus
without CD4 coreceptor requirement; (2) the recently de-
scribed class II-restricted CD8þ T cell subset that repre-
sents a high proportion of the CD8þ population of CD4/
mice (Tyznik et al, 2004).
Class II-restricted Treg cells (CD4þ25þ in wt mice) con-
trol the priming/expansion and functions of hapten-specific
CD8þ T cells in CHS (Dubois et al, 2003a, b). It is thus
possible that the decreased CD8þ CTL functions of CD4/
mice could be secondary to a potent suppressive effect
depending on Treg cells that could be found within the
CD4CD8 subset in CD4/ mice. Recent studies on the
role of the CD4 molecule in the differentiation of Treg cells
are in line with this hypothesis. Indeed, Denning et al (2003)
using mice with a mutation in the CD4 binding region
on MHC class II molecules, have shown that CD4/MHC
class II interaction is dispensable for the emergence
of CD4þCD25þ Treg cells, which are characterized by a
TCR with high affinity for class II/self-peptide complexes
(Jordan et al, 2001; Wang et al, 2001). More importantly, in
the absence of such CD4/class II interaction, higher num-
bers of functional Treg cells are produced in the thymus and
exported at the periphery (Denning et al, 2003). Since CD4/
MHC class II interaction cannot take place in CD4/ mice,
we postulate that similar abnormalities in T cell differenti-
ation occur leading to overexpansion of natural Treg cells
that are found in the CD4CD8 T cell subset.
Another explanation for the diminished CHS response in
CD4/ mice comes from the recent study of Tyznik et al
(2004) who reported two important observations on CD8
immunity to virus and bacteria in CD4/ mice. First, class
I-restricted CD8þ T cell responses to LCMV and to L.
monocytogenes were much weaker in CD4/ mice than in
wt mice, confirming these data. Second, CD4/ mice
contain a unique class II-restricted CD8þ T cell subset that
is not found in wt mice and comprises more than 50% of the
CD8þ T cell pool of the CD4/ mice. It is assumed that
these cells are selected by recognition of class II molecules
in the thymus and can be directed into the CD8 lineage
when the CD4 coreceptor is absent. More importantly
Tyznik et al (2004) found a correlation between the weak
CD8 effector function and the presence of class II-restricted
CD8þ T cells. Whether this peculiar CD8 subset could be
endowed with suppressive/regulatory functions able to
control the effector functions of class I-restricted CTL in
CD4/ mice remains to be determined.
Several groups have used class II-deficient mice, CD4/
 mice and wt mice acutely depleted in CD4þ T cells as
models to study the role of CD4þ T cells in CHS (Bour et al,
1995; Kondo et al, 1996; Bouloc et al, 1998; Krasteva et al,
1998; Wang et al, 2000; Akiba et al, 2002). These data as
well as our previous studies, clearly show that the three
models are not equivalent. Class II-deficient mice and mice
acutely depleted in CD4þ Tcells are the only models where
class II-restricted CD4þ T cells are deleted. Alternatively,
CD4/ mice have functional class II-restricted ‘‘wanabee’’
cells that mediate DTH reactions to proteins (Rahemtulla
et al, 1991; Locksley et al, 1993; and these results on DTH to
KLH). Thus, in keeping with the study of Tyznik et al (2004)
our data reveal that the CD4/ mice are a poor model for
the study of the contribution of CD4þ T cells in CHS, and
more generally for the study of the requirements for CD4þ
T cell help in mounting CD8þ T cell responses.
In conclusion, this study shows that the deficient CHS
response in CD4/ mice is not because of an intrinsic
defect in hapten-specific CD8þ T cell effectors but rather
to regulatory mechanisms, which remain to be clarified.
Materials and Methods
Mice C57BL/6 wt mice were purchased from Iffa-Credo (L’sA-
rbresle, France). Mice homozygous for the CD4 gene disruption
(CD4/) were originally obtained from Jackson Laboratory and
bred as homozygous. The heterozygous mice (CD4þ /) used as a
control were obtained by mating CD4/ mice with wt C57BL/6
mice. Mice with a mutation in the MHC class II Ab gene (class II/)
were kindly provided by C. Benoist and D. Mathis (Cosgrove et al,
1991). All the mice were on a C57BL/6 (H-2b) background and
were used between 8 and 12 wk of age. The CREA committee
approved all described studies.
Reagents and Ab DNFB was diluted in acetone:olive oil (AOO)
(4:1). FITC was diluted in acetone:dibutylphthalate (1:1). DNBS was
used for in vitro studies (all from SIGMA, St Louis, Missouri). FITC
TCR, PE CD8, PE CD11c, Cy-Chrome CD4 mAb, and hamster anti-
mouse CD3 (145-2c11) were purchased from BD Bioscience
(Le Pont de Claix, France).
CHS Mice were sensitized by epicutaneous application of 25 mL of
0.5% of DNFB onto 2 cm2 of fur shaved ventral skin. Five days
later, animals were challenged by application of 5 mL of 0.15%
DNFB onto each side of the right ear, whereas the same volume of
vehicle was applied on both sides of the contralateral ear. Ear
thickness measurements were taken for each ear prior to hapten
application with a spring-loaded micrometer (J15, Blet SA, Lyon,
France). Measurements were repeated once daily after challenge.
Ear swelling was calculated by subtracting the initial value from the
value recorded on the corresponding day, and further subtracting
any swelling recorded for the vehicle-control ear from the swelling
recorded for the hapten-challenged ear.
DTH to KLH Mice were injected s.c. on day 0 in the flank with 300
mg KLH and 100 mL of Complet Freund Adjuvant. The DTH reaction
was elicited 7 d later by injecting 150 mg KLH in the left hind foot-
pad. PBS was injected in the right hind footpad. Desensitized
mice were used as a control. Footpad swelling was calculated by
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subtracting the initial value from the value recorded on the corre-
sponding day, and further subtracting swelling of the PBS-injected
control footpad from swelling of the KLH-challenged footpad.
In vivo CD8þ T cell-depleted animals were injected with H35 mAb
at days 1, 0, þ 1, and þ 6. Depletion of CD8 T cells was routinely
498% as assessed by fluorescence-activated cell sorting (FACS)
analysis.
In vitro secondary T cell proliferation Axillary and inguinal LN
were harvested 5 d after DNFB sensitization and T cells were pu-
rified through negative selection using anti-Ig columns (Biotex,
Edmonton, Alberta, Canada). The resulting cells suspensions con-
tained 490% viable CD3þ cells. LN cells devoid of CD8þ T cells
(8) were obtained by elimination of CD8þ T cells using columns
coated with goat anti-rat IgG and a rat IgG anti-mouse CD8 mAb
(YTS191.1) (Biotex). FACS analysis of cells eluted from the column
showed o0.5% of contaminating CD8þ T cells. CD8þ T cell
population (8þ ) was purified (498% of purity) using magnetic cell
sorting (MACS) anti-CD8 microbeads following manufactural pro-
tocol (Miltenyi Biotec, Paris, France). In vivo hapten-primed un-
fractionated or CD8þ -depleted T cells (2.5  105 cells per well)
were cocultured for 3 d at 371C in 96-well plates with 106 irradiated
syngenic spleen cells from CD4/ or CD4þ / naive mice that
were either DNBS or TNBS treated as described (Krasteva et al,
1998) or left untreated. Preliminary experiments showed similar
results using APC from CD4/ and CD4þ / mice. The prolif-
erative responses were assessed on day 3 of culture by 3(H) thy-
midine incorporation (1 mCi per well) for the last 12 h of culture.
Multiprobe RNase protection assays IFN-g mRNA level was
measured by RNase protection assays using the Riboquant kit (BD
Bioscience) following the instructions of the supplier. The quantity
of protected RNA was determined using a PhosphorImager and
ImageQuant software (all from Molecular Dynamics, Sunnyvale,
California).
IFN-c ELISA assay Cell suspensions were recovered from axillary
and inguinal LN harvested on day 5 after DNFB sensitization and
were restimulated in vitro by coated anti-CD3 for 24 h. IFN-g pro-
tein level was measured by the R&D System DuoSet kit (Abingdon,
UK) following the manufacturer’s protocol.
Adoptive transfer of CHS Cell suspensions were recovered from
axillary and inguinal LN harvested on day 5 after DNFB sensitizat-
ion and CD8þ T cells were purified using the MACS protocol. 107
CD8þ T cells were adoptively transfered in the retroorbinal sinus
of naive class II/ recipient mice. 1 h later, mice were challenged
with 0.15% DNFB. Ear swelling was evaluated 48 h later.
Production of CTL DNBS-specific CTL were recovered from
splenocytes and purified T cells of CD4/, CD4þ /, and class
II/ mice. Spleens were recovered 5 d after cutaneous sen-
sitization with DNFB, perfused with RPMI to eliminate RBC. 107
splenocytes were used after restimulation for 5 d in culture with 107
irradiated DNBS-treated spleen cells from syngeneic mice (CD4þ /
, CD4/, class II/).
Target cells EL4 cells (H2b) were used as target cells and main-
tained in DMEM 2% FCS. EL4 cells were simultaneously hapten-
ated and labeled by incubating 2  106 cells in 10 mL of RPMI with
or without 40 mM DNBS and 100 mCi of 51Cr (sodium chromate
solution) for 1 h at 371C with periodic mixing. Labeled targets were
washed thoroughly before use.
Cytotoxicity assays Various numbers of effector cells were incu-
bated at 371C for 4 h with 104-labeled target cells. Supernatants
were then collected and 51Cr release was counted. The percent-
age of cytotoxicity was calculated using the formula:
100  ððexperimental c.p.m.
 spontaneous c.p.m.Þ=ðmaximal c.p.m.
 spontaneous c.p.m.ÞÞ
where the maximal c.p.m. and spontaneous c.p.m. are the radi-
oactivity released from targets exposed to 0.5 M HCl or medium,
respectively.
Extraction and RT-PCR analysis of CD8 and IFN-c mRNA Ear
samples were collected from sensitized or desensitized mice at
different times after challenge and frozen in liquid nitrogen. The
detection of RNA was conducted as described in detail elsewhere
(Akiba et al, 2002).
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